Video

What is the Future of Biosimilars?

Author(s):

Davy James, Managing Editor

CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.

CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.

Related Videos
Image credit: JJAVA | stock.adobe.com
Related Content
3D illustration of trastuzumab molecule | Image Credit: © LASZLO - stock.adobe.com
April 23rd 2025

Study Links PAK5 to Poor Outcomes and Drug Resistance in HER2-Positive Breast Cancer

Alexandra Gerlach, Associate Editor
Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange
April 14th 2025

Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange

Alexandra Gerlach, Associate Editor
CAR T cell therapy in leukemia -- Image credit: LASZLO | stock.adobe.com
April 23rd 2025

Introducing Obecabtagene Autoleucel: A New Chapter in ALL Treatment

Amir Ali, PharmD, BCOP Tammy Harutunyan, PharmD Candidate Arman Melikyan, PharmD Candidate
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Playing by the Oncology Pharmacogenomics Rules
April 23rd 2025

Playing by the Oncology Pharmacogenomics Rules

Benjamin Gibson, PharmD, PAHM
Carefully Dose and Taper Venetoclax to Avoid Tumor Lysis Syndrome
April 23rd 2025

Carefully Dose and Taper Venetoclax to Avoid Tumor Lysis Syndrome

Benjamin Gibson, PharmD, PAHM